Daniel Tai-Leung Chan, Ho-On Alston Conrad Chiu, Ka-Lam Wong, Ka-Chun Un, Kwong-Yue Eric Chan, Shu-Yue Sze, Chor-Cheung Frankie Tam, On-Yat Wong, Gilbert H L Tang, Simon Cheung-Chi Lam
{"title":"经股经导管主动脉瓣植入术（TF-TAVI）治疗伴有左心室辅助装置（LVAD）和主动脉反流的患者。","authors":"Daniel Tai-Leung Chan, Ho-On Alston Conrad Chiu, Ka-Lam Wong, Ka-Chun Un, Kwong-Yue Eric Chan, Shu-Yue Sze, Chor-Cheung Frankie Tam, On-Yat Wong, Gilbert H L Tang, Simon Cheung-Chi Lam","doi":"10.1002/ccd.70213","DOIUrl":null,"url":null,"abstract":"<p><p>Aortic regurgitation (AR) develops in up to 25%-30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri-operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF-TAVI) with non-dedicated devices technically challenging. We present a case series wherein a TF J-Valve system, a dedicated transcatheter heart valve for pure AR, emerges as an alternative treatment for AR in patients with an LVAD. We demonstrate successful deployment even in the presence of challenging anatomy including aortic root thrombus. Technical considerations when performing TF-TAVI in LVAD patients are discussed.</p>","PeriodicalId":520583,"journal":{"name":"Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation.\",\"authors\":\"Daniel Tai-Leung Chan, Ho-On Alston Conrad Chiu, Ka-Lam Wong, Ka-Chun Un, Kwong-Yue Eric Chan, Shu-Yue Sze, Chor-Cheung Frankie Tam, On-Yat Wong, Gilbert H L Tang, Simon Cheung-Chi Lam\",\"doi\":\"10.1002/ccd.70213\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Aortic regurgitation (AR) develops in up to 25%-30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri-operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF-TAVI) with non-dedicated devices technically challenging. We present a case series wherein a TF J-Valve system, a dedicated transcatheter heart valve for pure AR, emerges as an alternative treatment for AR in patients with an LVAD. We demonstrate successful deployment even in the presence of challenging anatomy including aortic root thrombus. Technical considerations when performing TF-TAVI in LVAD patients are discussed.</p>\",\"PeriodicalId\":520583,\"journal\":{\"name\":\"Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/ccd.70213\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ccd.70213","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation.
Aortic regurgitation (AR) develops in up to 25%-30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri-operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF-TAVI) with non-dedicated devices technically challenging. We present a case series wherein a TF J-Valve system, a dedicated transcatheter heart valve for pure AR, emerges as an alternative treatment for AR in patients with an LVAD. We demonstrate successful deployment even in the presence of challenging anatomy including aortic root thrombus. Technical considerations when performing TF-TAVI in LVAD patients are discussed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
